series-c-plus
Stage
2024
Founded
1
Investors
About
Ariz Bio develops targeted cancer therapeutics by focusing on epigenetic changes in cancer cells, utilizing precision medicine approaches that combine biological and nanotechnologies to stop cancer at its root cause.
Explore Ariz Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.